Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
SAYANA Inj Susp 104 mg/0.65ml Einwegspr
Drug
Sayana, Injektionssuspension
Parenterales Kontrazeptivum
09.02.1. – homonal contraceptives
HAM – Human medicine
SUPA – Parenteral suspension
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
4/5/2012
9/30/2025
Dosage strength
Sayana, Injektionssuspension (104 mg/0.65 ml)
Parenterales Kontrazeptivum
01
Z – approved
Package
7680620740017
In trade from / since 4/5/2012
A/R – Authorised / referenced
1 syringe(s)
001
Z – approved
Declaration
Component
104 mg medroxyprogesteroni acetas
natrii chloridum
macrogolum 3350
polysorbatum 80
natrii dihydrogenophosphas monohydricus
dinatrii phosphas dodecahydricus
povidonum K 17
methioninum
0.1 mg propylis parahydroxybenzoas
1.04 mg E 218
aqua ad iniectabile
2.158 mg natrium
macrogolum 3350
polysorbatum 80
natrii dihydrogenophosphas monohydricus
dinatrii phosphas dodecahydricus
povidonum K 17
methioninum
0.1 mg propylis parahydroxybenzoas
1.04 mg E 218
aqua ad iniectabile
2.158 mg natrium
Authorisation holder
7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)
Schärenmoosstrasse 99
8052 Zürich (ZH)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.